X0306 5 2014-12-31 0 0 1 0001042418 HedgePath Pharmaceuticals, Inc. HPPI 0001510349 Hasara Garrison J. 324 S. HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606 0 1 0 0 CFO and Treasurer Restricted Stock Units 2014-08-06 4 A 0 3500000 0.00 A Common Stock 3500000 3500000 D Restricted Stock Units 2014-08-06 4 A 0 3500000 0.00 A Common Stock 3500000 3500000 D Each restricted stock unit represents a right to receive one share of the issuer's common stock. The restricted stock units were issued to the reporting person on August 6, 2014, pursuant to a grant under the issuer's 2014 Equity Incentive Plan. The restricted stock units will vest on the earlier to occur of (i) September 3, 2016 and (ii) the receipt of written notice of acceptance for the filing of an NDA by the issuer for the its patented formulation of the drug itraconazole, known as SUBATM-Itraconazole, in a particular dose formulation for the treatment of human patients with cancer via oral administration. The restricted stock units were issued to the reporting person on August 6, 2014, pursuant to a grant under the issuer's 2014 Equity Incentive Plan. The restricted stock units will vest on September 3, 2017. /s/ Garrison J. Hasara 2015-02-06